Mounjaro UK prices rose by up to 170% in September 2025. Learn why costs increased, how this affects patients, Mounjaro vs Wegovy comparisons, and safe support options. 

Why Has the Mounjaro Price Increased? 

On 1 September 2025, the cost of Mounjaro in the UK rose sharply after a decision by Eli Lilly, the manufacturer. They explained that the price increase was made to bring the UK in line with Europe and other developed countries. 

This is a national change — it affects all providers across the UK. 

The Human Impact: A Patient Story 

When a relative first told me about the price increase and how he could no longer afford the treatment that had transformed his health, it reminded me of when I bought our caravan. At first, it was our happy place — a source of freedom and comfort. But as costs crept up, it began to feel out of reach. 

For many patients, Mounjaro has been that same “happy place” — helping them feel healthier, more confident, and more in control. So, it’s understandable that the price rise feels frustrating, even devastating. 

What Does This Mean for Patients? 

We know this change will raise difficult questions: 

  • Can I afford to continue treatment? 
  • Are there alternatives? 
  • Will this affect my weight loss progress? 

These are real concerns. While general practice clinicians don’t prescribe or monitor Mounjaro or Wegovy, we can guide patients to safe, reliable sources of support. 

Safe Places to Find Advice 

  • Your GP or NHS weight management service – for personalised clinical advice. 
  • Registered private providers (pharmacies or online doctors) – who can prescribe and adjust treatment. 
  • Trusted online information – avoid unregulated websites or unverified medicine sources. 

Mounjaro vs Wegovy: Key Differences 

  • Mounjaro (tirzepatide): Acts on two receptors (GLP-1 and GIP). Associated with ~21% weight loss on average. 
  • Wegovy (semaglutide): Acts on one receptor (GLP-1). Associated with ~15% weight loss on average. 
  • Both: Weekly injections, but only a prescribing clinician can assess which option is best for each patient. 

Some patients may choose to stay on Mounjaro if it’s affordable, others may switch to Wegovy (which recently fell in price), and some may pause medication while focusing on lifestyle and support programmes. 

You’re Not Alone 

If the Mounjaro price rise feels overwhelming, remind patients they are not alone. Many are rethinking their options right now. 

Medicines can be part of the journey, but lasting results also come from routines, support networks, and lifestyle changes. Just like with my caravan story — costs changed how we used it, but we still found joy in different ways. 

Patients can continue their journey too, even if it looks different than they first imagined. 

For Clinicians: Supporting Through Change 

If you’re a clinician helping patients through treatment changes and communication challenges, the Aligned Care Programme offers tools to strengthen listening, guidance, and care — even when the world of medications gets messy. 

Learn more about the Aligned Care Programme → Aligned Care Personalised Care Diploma | MA Training Enterprise